A positive role for PEA3 in HER2-mediated breast tumour progression

This publication has 23 references indexed in Scilit:

• Expression of PEA3 and Lack of Correlation Between PEA3 and HER-2/neu Expression in Breast Cancer
  Breast Cancer Research and Treatment, 2006
• Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
  New England Journal of Medicine, 2005
• Associations and Interactions between Ets-1 and Ets-2 and Coregulatory Proteins, SRC-1, AIB1, and NCoR in Breast Cancer
  Clinical Cancer Research, 2005
• Expression of SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1
  Journal of Clinical Pathology, 2004
• Biologic and therapeutic role of HER2 in cancer
  Oncogene, 2003
• Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer
  Oncogene, 2002
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
  Proceedings of the National Academy of Sciences, 2001
• Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2
  Oncogene, 1997
• Oncogene amplification and prognosis in breast cancer: Relationship with systemic treatment
  Gene, 1995
• Molecular cloning and characterization of PEA3, a new member of the Ets oncogene family that is differentially expressed in mouse embryonic cells.
  Genes & Development, 1992